Literature DB >> 19636636

Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy.

Shang-Yu Wang1, Chun-Nan Yeh, Hsiang-Lin Lee, Yu-Yin Liu, Tzu-Chieh Chao, Tsann-Long Hwang, Yi-Yin Jan, Miin-Fu Chen.   

Abstract

BACKGROUND: The clinical impact of positive surgical margin on the overall survival and recurrence pattern for gastric cancer (GC) patients undergoing intension curative resection has not yet been well investigated. PATIENTS AND METHODS: The clinical features of 1,565 patients with histologically proven GC who underwent intension curative resection from 1994 to 2004 were retrospectively reviewed. Among them, 129 (8.2%) had positive microscopic resection margin. The clinicopathological features and the outcome of 1,436 GC patients undergoing gastrectomy with negative resection margin were used for comparison.
RESULTS: GC patients who underwent gastrectomy with higher T, N stage, and tumor size larger than 5 cm tended to have positive resection margin when compared with those with negative margin. Median follow-up duration for the 1,565 GC patients who underwent intension curative resection was 28.6 months. The overall survival (OS) rate significantly decreased when the patients had positive resection margin, irrespective of different stages. When GC patients underwent gastrectomy with positive resection margin, positive nodal metastasis determined the worst OS. Distant metastasis was the most common site of recurrence, followed by peritoneal and locoregional recurrence.
CONCLUSIONS: Aggressive tumor biology might be the main factor contributing to positive microscopic resection margin after gastrectomy. Positive resection margin had a definite unfavorable impact on the OS of gastric cancer patients undergoing gastrectomy. When GC patients underwent gastrectomy with positive resection margin, positive nodal metastasis determined the worst OS, and distant metastasis was the most common site of recurrence.

Entities:  

Mesh:

Year:  2009        PMID: 19636636     DOI: 10.1245/s10434-009-0616-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  36 in total

1.  Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.

Authors:  Jun-Te Hsu; Tse-Ching Chen; Jeng-Hwei Tseng; Cheng-Tang Chiu; Keng-Hao Liu; Chun-Nan Yeh; Tsann-Long Hwang; Yi-Yin Jan; Ta-Sen Yeh
Journal:  Oncologist       Date:  2011-12-05

2.  A decade in gastric cancer curative surgery: Evidence of progress (1999-2009).

Authors:  Stefano Rausei; Gianlorenzo Dionigi; Francesca Rovera; Luigi Boni; Caterina Valerii; Luisa Giavarini; Francesco Frattini; Renzo Dionigi
Journal:  World J Gastrointest Surg       Date:  2012-03-27

Review 3.  Updating controversies on the multidisciplinary management of gastric cancer.

Authors:  Javier Lacueva; Javier Gallego; Juan Antonio Díaz-González
Journal:  Clin Transl Oncol       Date:  2010-10       Impact factor: 3.405

4.  Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection.

Authors:  Jung-Woo Woo; Keun Won Ryu; Ji Yeon Park; Bang Wool Eom; Mi Jung Kim; Hong Man Yoon; Sook Ryun Park; Myeong-Cherl Kook; Il Ju Choi; Young-Woo Kim; Young-Iee Park
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

5.  Preoperative endoscopic tattooing using India ink to determine the resection margins during totally laparoscopic distal gastrectomy for gastric cancer.

Authors:  Yuta Yamazaki; Shingo Kanaji; Gosuke Takiguchi; Naoki Urakawa; Hiroshi Hasegawa; Masashi Yamamoto; Yoshiko Matsuda; Kimihiro Yamashita; Takeru Matsuda; Taro Oshikiri; Tetsu Nakamura; Satoshi Suzuki; Yoshihiro Kakeji
Journal:  Surg Today       Date:  2020-06-27       Impact factor: 2.549

Review 6.  [R1 resection for gastric carcinoma].

Authors:  K Ridwelski; J Fahlke; M Huß; R Otto; S Wolff
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

7.  ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

Authors:  Nelson Adami Andreollo; Eric Drizlionoks; Valdir Tercioti-Junior; João de Souza Coelho-Neto; José Antonio Possato Ferrer; José Barreto Campello Carvalheira; Luiz Roberto Lopes
Journal:  Arq Bras Cir Dig       Date:  2019-12-20

8.  Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer.

Authors:  Chang Min Lee; Ye Seob Jee; Ju-Hee Lee; Sang-Yong Son; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

9.  Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancer for magnifying endoscopy with narrow-band imaging: surgical cases.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Tomoki Shimizu; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Masahiro Igarashi; Hiroshi Takahashi
Journal:  Surg Endosc       Date:  2016-08-29       Impact factor: 4.584

10.  Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study.

Authors:  Meng-Long Zhou; Gui-Chao Li; Wang Yang; Wei-Juan Deng; Ran Hu; Yan Wang; Zi-Wen Long; Xiao-Wen Liu; Ya-Nong Wang; Zhen Zhang
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.